BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200303
DTEND;VALUE=DATE:20200305
DTSTAMP:20260515T064614
CREATED:20191215T130603Z
LAST-MODIFIED:20191215T130603Z
UID:23348-1583193600-1583366399@www.pharmajournalist.com
SUMMARY:Animal Microbiome & Nutritional Health Congress
DESCRIPTION:Building on the huge success of our European Animal Microbiome Congress in London this past July\, we are incredibly excited to return to the USA in March 2020\, this time in Chicago\, Illinois. \n \nInterest in animal microbiomes as therapeutics is rapidly expanding\, as techniques to study the microbial world decrease in cost and increase in accessibility\, and case studies from human medicine receive widespread attention. The current state of techniques and strategies to modify the microbiome to improve animal health\, focusing on applications in domestic pets and farm animals\, will be the main focus of this event. \nWe will be untangling the basic biology of microbiome-directed therapies in animals and the examples to date of application of probiotics\, prebiotics\, and other microbiome-directed therapies and feed additives being used to benefit animal health. We will also be looking heavily at the impact of different feed and nutrition profiles on animal microbiomes\, and the power of nutrition in affecting animal health in a beneficial way. \nFinally\, the event will host the Animal Microbiome & Nutritional Health Innovation Showcase\, where 8 emerging companies in the field of animal nutrition will present the microbiome and nutritional solutions they can bring to market. \nTo learn more about this event and to register online\, visit https://animalmicrobiomecongressusa.com/
URL:https://www.pharmajournalist.com/event/animal-microbiome-nutritional-health-congress/
LOCATION:Warwick Allerton – Chicago\, 701 N Michigan Avenue\, Chicago\, IL\, 60611\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200303
DTEND;VALUE=DATE:20200306
DTSTAMP:20260515T064614
CREATED:20191215T131423Z
LAST-MODIFIED:20191215T131423Z
UID:23352-1583193600-1583452799@www.pharmajournalist.com
SUMMARY:Gene Therapy for Blood Disorders
DESCRIPTION:Discover the Clinical & Commercial Potential of Gene Therapy & Editing Approaches Revolutionizing Hemophilia\, Sickle Cell Disease & β-Thalassemia Treatment \nRevolutionary gene therapies are redefining the treatment of blood diseases. \n \nWith an approved gene therapy treatment for β-thalassemia in the EU\, and hemophilia candidates seeking 2020 approval in the USA and beyond\, pioneers in the space must overcome hurdles they have never previously encountered to transform their clinical candidates into a commercial reality. Gene Therapy for Blood Disorders will unite industry leaders across the blood disease space to delve into the specific clinical and commercial challenges faced by companies developing gene therapies for hemophilia\, sickle cell disease and\nβ-thalassemia. \nEvaluate the best strategies for a commercial launch in blood disease\, optimize your trial design\, gain insights on revolutionary novel technologies\, and ultimately enhance your current hematology gene therapy program to bring transformative treatments to patients more quickly and efficiently. \nDownload the full event guide to learn more from companies including bluebird bio\, Spark Therapeutics and Editas Medicine
URL:https://www.pharmajournalist.com/event/gene-therapy-for-blood-disorders/
LOCATION:Courtyard Boston Downtown\, 275 Tremont Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR